Systematic review for the development of a pharmaceutical and medical products prioritization framework

被引:4
|
作者
Frutos Perez-Surio, Alberto [1 ,2 ]
Gimeno-Gracia, Mercedes [1 ,3 ]
Alcacera Lopez, Ma Aranzazu [1 ]
Sagredo Samanes, Ma Asuncion [1 ]
Pardo Jario, Ma del Puerto [1 ]
Salvador Gomez, Ma del Transito [1 ]
机构
[1] Univ Clin Hosp Lozano Blesa, Dept Hosp Pharm, Avda San Juan Bosco 15, Zaragoza 50009, Spain
[2] Univ Zaragoza, Dept Microbiol Prevent Med & Publ Hlth, C Domingo Miral S-N, Zaragoza 50009, Spain
[3] IIS Aragon, Zaragoza, Spain
关键词
Pharmaceuticals; Medical products; Health technology assessment; Decision-making; Health priorities; Criteria resource allocation; HEALTH TECHNOLOGY-ASSESSMENT; MULTICRITERIA DECISION-ANALYSIS; CARE; CRITERIA; POLICY; HTA;
D O I
10.1186/s40545-019-0181-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveTo identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.Data sourcesWe performed a search of the main biomedical databases (Medline/PubMed, Embase, Centre for Reviews and Dissemination, and Cochrane), and we reviewed assessment agency websites, among other sources.Study designAn systematic review of the literature was carried out.Data collectionEligibility criteria for inclusion were based on set of predefined criteria. Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. A critical analysis is made of all the aspects that may be useful for any public body that intends to establish priorities in health.Principal findingsWe found that there are no standardized criteria for priority setting, although common trends have been identified regarding key elements. Eight key domains were identified: 1) need for intervention; 2) health outcomes; 3) type of benefit of the intervention; 4) economic consequences; 5) existing knowledge on the intervention/quality and uncertainties of the regarding evidence; 6) implementation and complexity of the intervention/feasibility; 7) justice and ethics; and 8) overall context.ConclusionsOur review provides a thorough analysis of the relevant issues and offers key recommendations regarding considerations for developing a national prioritization framework. Findings are envisioned to be useful for different public organizations that are aiming to establish healthcare priorities.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Enhancing Agile Software Development: A Systematic Literature Review of Requirement Prioritization and Reprioritization Techniques
    Tasneem, Noshin
    Zulzalil, Hazura Binti
    Hassan, Sa'Adah
    IEEE ACCESS, 2025, 13 : 32993 - 33034
  • [22] A Systematic Literature Review of Requirements Prioritization Criteria
    Riegel, Norman
    Doerr, Joerg
    REQUIREMENTS ENGINEERING: FOUNDATION FOR SOFTWARE QUALITY ( REFSQ 2015), 2015, 9013 : 300 - 317
  • [23] Medical tourism development: A systematic review of economic aspects
    Hadian, Marziye
    Jabbari, Alireza
    Mousavi, Seyed Hossein
    Sheikhbardsiri, Hojjat
    INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 2021, 14 (02) : 576 - 582
  • [24] Assessing empathy development in medical education: a systematic review
    Sulzer, Sandra H.
    Feinstein, Noah W.
    Wendland, Claire L.
    MEDICAL EDUCATION, 2016, 50 (03) : 300 - 310
  • [25] Advancing Faculty Development in Medical Education: A Systematic Review
    Leslie, Karen
    Baker, Lindsay
    Egan-Lee, Eileen
    Esdaile, Martina
    Reeves, Scott
    ACADEMIC MEDICINE, 2013, 88 (07) : 1038 - 1045
  • [27] Pharmaceutical products, drugs and personal care products in European waters: A protocol for systematic review and meta-analysis
    Serrano Valera, Manuel
    Martinez-Alcala, Isabel
    Piuvezam, Grasiela
    Mateo-Ramirez, Francisco
    Pimenta, Isac Davidson Santiago Fernandes
    Vela, Nuria
    PLOS ONE, 2024, 19 (08):
  • [28] Integrated SEM-FTOPSIS framework for modeling and prioritization of risk sources in medical device development process
    Kirkire, Milind Shrikant
    Rane, Santosh B.
    Singh, Surya Prakash
    BENCHMARKING-AN INTERNATIONAL JOURNAL, 2018, 25 (01) : 178 - 200
  • [29] SYSTEMATIC ELIMINATION OF PHARMACEUTICAL PRODUCTS IS NOT OUR GOAL
    SCHNIEDERS, B
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1981, 123 (24): : 975 - 976
  • [30] Gluten in pharmaceutical products: a scoping review
    Lizano-Diez, Irene
    Marino, Eduardo L.
    Modamio, Pilar
    SYSTEMATIC REVIEWS, 2021, 10 (01)